# Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery

> **NCT03314025** · PHASE2 · UNKNOWN · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 158 (estimated)

## Conditions studied

- Urinary Retention

## Interventions

- **DRUG:** Tamsulosin Hydrochloride 0.4 MG
- **DRUG:** Placebo oral capsule
- **DEVICE:** Foley catheter

## Key facts

- **NCT ID:** NCT03314025
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-06
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2021-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314025, "Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03314025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*